Aura Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	25.41	41.06	121.58	149.06	17.39	32.45
Short-Term Investments	148.97	185.09	67.23	-	-	-
Cash & Short-Term Investments	174.38	226.15	188.81	149.06	17.39	32.45
Cash Growth	16.99%	19.78%	26.67%	757.03%	-46.40%	-
Prepaid Expenses	0.35	1.82	2.17	2.73	0.05	0.05
Restricted Cash	-	0.02	0.02	0.02	0.02	0.02
Other Current Assets	8.75	3.81	5.7	1.88	0.99	0.83
Total Current Assets	183.48	231.79	196.7	153.7	18.46	33.35
Property, Plant & Equipment	21.07	22	26.04	6.2	3.57	3.63
Other Long-Term Assets	0.79	1.28	1.19	0.13	0.08	0.08
Total Assets	205.34	255.08	223.94	160.03	22.1	37.06
Accounts Payable	1.99	1.79	2.92	2.4	0.61	2.33
Accrued Expenses	8.54	6.95	4.25	3.83	1.77	3.41
Current Portion of Leases	3.13	2.69	2.96	0.62	-	-
Other Current Liabilities	1.06	0.94	0.33	0.51	0.28	0.41
Total Current Liabilities	14.71	12.36	10.46	7.36	2.66	6.15
Long-Term Debt	-	-	-	-	-	0.05
Long-Term Leases	15.96	16.87	17.9	0.36	-	-
Other Long-Term Liabilities	-	-	-	-	0.08	0.1
Total Liabilities	30.67	29.23	28.35	7.72	2.74	6.29
Additional Paid-In Capital	522.45	512.62	406.56	304.45	8.17	7.27
Retained Earnings	-348.39	-287.31	-210.9	-152.14	-116.89	-94.68
Comprehensive Income & Other	0.61	0.54	-0.07	-	-	-
Total Common Equity	174.67	225.85	195.58	152.32	-108.71	-87.41
Shareholders' Equity	174.67	225.85	195.58	152.32	19.36	30.76
Total Liabilities & Equity	205.34	255.08	223.94	160.03	22.1	37.06
Total Debt	19.08	19.56	20.86	0.98	-	0.05
Net Cash (Debt)	155.29	206.59	167.95	148.09	17.39	32.4
Net Cash Growth	20.51%	23.01%	13.41%	751.42%	-46.32%	-
Net Cash Per Share	3.21	5.21	5.61	28.70	47.37	95.77
Filing Date Shares Outstanding	49.95	49.5	37.8	29.22	0.44	0.34
Total Common Shares Outstanding	49.78	49.35	37.77	29.21	0.38	0.34
Working Capital	168.77	219.44	186.25	146.35	15.79	27.2
Book Value Per Share	3.51	4.58	5.18	5.21	-285.22	-258.36
Tangible Book Value	174.67	225.85	195.58	152.32	-108.71	-87.41
Tangible Book Value Per Share	3.51	4.58	5.18	5.21	-285.22	-258.36
Machinery	8.3	7.8	7.43	5.64	4.77	3.85
Construction In Progress	0.52	0.39	1.81	2.37	1.15	1.2
Leasehold Improvements	0.47	-	-	0.01	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.